Literature DB >> 21503538

[Primary Sjögren's syndrome: exocrine and non-exocrine manifestations].

Maria da Graça Henriques da Conceição Negrão Sequeira Muñoz1, Walter Carlos Baptista Castelão, Fernando Manuel Diamantino Saraiva, José Carlos Teixeira da Costa, Mário Fernando Oliveira Viana de Queiroz.   

Abstract

OBJECTIVE: to characterize the exocrine and non-exocrine clinical disease manifestations of 74 patients with primary Sjögren's Syndrome (pSS).
METHODS: retrospective study of pSS patients according to the new 2002 American-European criteria, followed in the Hospital Santa Maria, Rheumatology Outpatient Clinics, in the last 25 years (mean follow-up of 7.7 years).
RESULTS: all patients presented surface exocrine disease, especially xerostomia and keratoconjunctivitis sicca. Internal organ exocrine disease was found in 25 patients (33.8%), whilst only one patient (1.4%) developed monoclonal B lymphocyte disease (pulmonary pseudolymphoma). Fifty-five patients (74.3%) also displayed non-exocrine manifestations, in particular inflammatory mediator-induced disease (68.9%). Inflammatory vascular disease was present in 54% of patients and noninflammatory vascular disease in 27%. Autoimmune thyroiditis was found in 5 patients (6.8%).
CONCLUSIONS: the disease is dominated by oral and ocular involvement, while severe organic manifestations are less frequent. This classification model allows a comparison of patients with physiopathological abnormalities and offers the possibility of finding markers of activity/cronicity related to them.

Entities:  

Year:  2004        PMID: 21503538     DOI: 10.1590/s0482-50042004000200005

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  1 in total

1.  Frequent involvement of central nervous system in primary Sjögren syndrome.

Authors:  Isabel Moreira; Filipa Teixeira; Ana Martins Silva; Carlos Vasconcelos; Fátima Farinha; Ernestina Santos
Journal:  Rheumatol Int       Date:  2014-07-24       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.